Erschienen in:
01.06.2011 | Letter
Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects?
verfasst von:
Pieter R Tuinman, Nicole P Juffermans
Erschienen in:
Critical Care
|
Ausgabe 3/2011
Einloggen, um Zugang zu erhalten
Excerpt
Dr Lorente and colleagues [
1] report on the interesting association between serum soluble CD40 ligand (sCD40L) levels and mortality in patients with sepsis. Some variables that can influence outcome in sepsis were accounted for in their analysis. However, the amount of transfused blood products, which may influence levels of sCD40L, was not reported. …